Normalization of hormonal imbalances, ovarian follicular dynamics and metabolic effects in follitrophin receptor knockout mice

Molecular Human Reproduction

Volumn 13, Issue 5, 2007, Pages 287-297

  Tiwari Pandey, Rashmi ^a   Yang, Yinzhi ^a   Aravindakshan, Jayaprakash ^a   Sairam, M Ram ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Androgen receptor; Hyperandrogenemia; Obesity; Oocyte; Stromal hyperplasia

Indexed keywords

ESTRADIOL; ESTROGEN; FOLLITROPIN RECEPTOR; GONADOTROPIN; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; STEROID HORMONE; TESTOSTERONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOCRINE DISEASE; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; ESTRUS CYCLE; FEMALE; GRANULOSA CELL; HYPERANDROGENISM; KNOCKOUT MOUSE; MAMMARY GLAND; MOUSE; MUTANT; NEGATIVE FEEDBACK; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; ORGAN TRANSPLANTATION; OVARY FOLLICLE; OVARY FUNCTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; UTERUS FUNCTION;

MUS;

EID: 34447336144     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gam008     Document Type: Article

References (50)

1. Abel MH, Wootton AN, Wilkins V, Huhtaniemi I, Knight PG and Charlton HM (2000) The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. Endocrinology 141,1795-1803.
2. Babu PS, Krishnamurthy H, Chedrese PJ and Sairam MR (2000) Activation of extracellular-regulated kinase pathways in ovarian granulosa cells by the novel growth factor type 1 follicle-stimulating hormone receptor. Role in hormone signaling and cell proliferation. J Biol Chem 275,27615-27626.
3. Balla A, Danilovich N, Yang Y and Sairam MR (2003) Dynamics of ovarian development in the FORKO immature mouse: Structural and functional implications for ovarian reserve. Biol Reprod 69,1281-1293.
4. Bogovich K and Richards JS (1982) Androgen biosynthesis in developing ovarian follicles: Evidence that luteinizing hormone regulates thecal 17 alpha-hydroxylase and C17-20-lyase activities. Endocrinology 111,1201-1208.
5. Burns KH, Yan C, Kumar TR and MatzukMM(2001) Analysis of ovarian gene expression in follicle-stimulating hormone beta knockout mice. Endocrinology 142,2742-2751.
6. Cheng G, Weihua Z, Makinen S, Makela S, Saji S, Warner M, Gustafsson JA and Hovatta O (2002) A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary. Biol Reprod 66,77-84.
7. Couse JF, Lindzey J, Grandien K, Gustafsson JA and Korach KS (1997) Tissue distribution and quantitative analysis of estrogen receptor-α (ER-α) and estrogen receptor-β (ER-β) messenger ribonucleic acid in the wild type and ERα-knockout mouse. Endocrinology 138,4613-4621.
8. Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H and Sairam MR (2000) Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 141,4295-4308.
9. Danilovich N, Roy I and Sairam MR (2001) Ovarian pathology and high incidence of sex cord tumors in follitropin receptor knockout (FORKO) mice. Endocrinology 142,3673-3684.
10. Danilovich N, Javeshghani D, Xing W and Sairam MR (2002) Endocrine alterations and signaling changes associated with declining ovarian function and advanced biological aging in follicle-stimulating hormone receptor haploinsufficient mice. Biol Reprod 67,370-378.
11. Danilovich N, Maysinger D and Sairam MR (2004) Perspectives on reproductive senescence and biological aging: Studies in genetically altered follitropin receptor knockout [FORKO] mice. Exp Gerontol 39,1669-1678.
12. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M and Sassone-Corsi P (1998) Impairing follicle-stimulating hormone (FSH) signaling in vivo. Targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA 95,13612-13617.
13. Duleba AJ, Spaczynski RZ, Olive DL and Behrman HR (1997) Effects of insulin and insulin-like growth factors on proliferation of rat ovarian theca-interstitial cells. Biol Reprod 56,891-897.
14. Eberspaecher U, Becker A, Bringmann P, van der ML and Donner P (2001) Immunohistochemical localization of zona pellucida proteins ZPA, ZPB and ZPC in human, cynomolgus monkey and mouse ovaries. Cell Tissue Res 303,277-287.
15. Eppig JJ, Wigglesworth K and Pendola FL (2002) The mammalian oocyte orchestrates the rate of ovarian follicular development. Proc Natl Acad Sci USA 99,2890-2894.
16. Foth D and Romer TH (2001) Postmenopausal hyperandrogenemia (android obesity, insulin resistance, diabetes mellitus) and therapeutic consequences. In Fischl FH (ed.) Hormone Replacement Therapy Through the Ages, New Cognition and Therapy Concepts: Menopause Andropause. Krause & Pachernegg GmbH, Austria, pp. 159-163.
17. Givens JR, Wiser WL, Coleman SA, Wilroy RS, Andersen RN, Fish SA and Watson BS (1971) Familial ovarian hyperthecosis: A study of two families. Am J Obstet Gynec 110,959-972.
18. Gosden RG, Boulton MI, Grant K and Webb R (1994) Follicular development from ovarian xenografts in SCID mice. J Reprod Fertil 101,619-623.
19. Hild-Petito S, West NB, Brenner RM and Stouffer RL (1991) Localization of androgen receptor in the follicle and corpus luteum of the primate ovary during the menstrual cycle. Biol Reprod 44,561-568.
20. Homburg R, Pariente C, Lunenfeld B and Jacobs HS (1992) The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome. Hum Reprod 7,1379-1383.
21. Indrapichate K, Meehan D, Lane TA, Chu SY, Rao CV, Johnson D, Chen TT and Wimalasena J (1992) Biological actions of monoclonal luteinizing hormone/human chorionic gonadotropin receptor antibodies. Biol Reprod 46,265-278.
22. Judd HI and Korenman SG (1982) Aging and reproductive function in women. In Korenman SG (ed.) Endocrine Aspects of Aging. Elsevier Biomedical, New York, p. 169.
23. Krug E and Berga SL (2002) Postmenopausal hyperthecosis: Functional dysregulation of androgenesis in climacteric ovary. Obstet Gynecol 99,893-897.
24. Longcope C (2001) Endocrine function of the postmenopausal ovary. J Soc Gynecol Investig 8,S67-S68.
25. Magoffin DA (2005) Ovarian theca cell. Int J Biochem Cell Biol 37,1344-1349.
26. Martinez ML, Fontenot GK and Harris JD (1996) The expression and localization of zona pellucida glycoproteins and mRNA in cynomolgus monkeys (Macaca fascicularis). J Reprod Fertil 50, 35-41.
27. Mowa CN and Iwanaga T (2000) Differential distribution of oestrogen receptor α and β mRNA in the female reproductive organ of rats as revealed by in situ hybridization. J Endocrinol 165,59-66.
28. Nilsson S, Kuiper GG and Gustafsson JA (1998) ER β: A novel estrogen receptor offers the potential for new drug development. Trends Endocrinol Metab 9,387-395.
29. Olefsky JM and Reaven GM (1975) Effects of age and obesity on insulin binding to isolated adipocytes. Endocrinology 96,1486-1498.
30. Pakarainen T, Zhang FP, Poutanen M and Huhtaniemi I (2005) Fertility in luteinizing hormone receptor-knockout mice after wild-type ovary transplantation demonstrates redundancy of extragonadal luteinizing hormone action. J Clin Invest 115,1862-1868.
31. Pan J, Sasanami T, Kono Y, Matsuda T and Mori M (2001) Effects of testosterone on production of perivitelline membrane glycoprotein ZPC by granulosa cells of Japanese quail (Coturnix japonica). Biol Reprod 64,310-316.
32. Patsoula E, Loutradis D, Drakakis P, Kallianidis K, Bletsa R and Michalas S (2001) Expression of mRNA for the LH and FSH receptors in mouse oocytes and preimplantation embryos. Reproduction 121,455-461.
33. Prior JC (1998) Perimenopause: The complex endocrinology of the menopausal transition. Endoc Rev 19,397-428.
34. Rankin TL, O'Brien M, Lee E, Wigglesworth K, Eppig J and Dean J (2001) Defective zonae pellucidae in Zp2-null mice disrupt folliculogenesis, fertility and development. Development 128,1119-1126.
35. Robker R and Richards JS (1998) Hormonal control of the cell cycle in ovarian cells: Proliferation versus differentiation. Biol Reprod 59,476-482.
36. Russo IH, Tewari M and Russo J (1989) Morphology and development of the rat mammary gland. In Jones TC Mohr U and Hunt RD (eds.) Integument and Mammary Glands. Springer-Verlag, Berlin, pp. 233-252.
37. Sairam MR, Danilovich N and Lussier-Cacan S (2002) The FORKO mouse as a model for exploring estrogen replacement therapy. J Reprod Med 47,412-418.
38. Sairam MR, Wang M, Danilovich N, Javeshghani D and Maysinger D (2006) Early obesity and age-related mimicry of metabolic syndrome in female mice with sex hormonal imbalances. Obesity 14,1142-1154.
39. Shemesh M (2001) Actions of gonadotrophins on the uterus. Reproduction 121,835-842.
40. Shifren J and Schiff I (2000) The aging ovary. J Womens Health Gend Based Med 9,S3-S7.
41. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD et al. (1996) Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384,470-474.
42. Simoni M, Gromoll J and Nieschlag E (1997) The follicle-stimulating hormone receptor: Biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18,739-773.
43. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H et al. (2006) FSH directly regulates bone mass. Cell 125,247-260.
44. Turgeon JL, McDonnell DP, Martin KA and Wise PM (2004) Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304,1269-1273.
45. Vendola K, Zhou J, Wang J, Famuyiwa OA, Bievre M and Bondy CA (1999) Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod 61,353-357.
46. Weil S, Vendola K, Zhou J and Bondy CA (1999) Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 84,2951-2956.
47. Weissman A, Gotlieb L, Colgan T, Jurisicova A, Greenblatt EM and Casper RF (1999) Preliminary experience with subcutaneous human ovarian cortex transplantation in the NOD-SCID mouse. Biol Reprod 60,1462-1467.
48. Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. J Am Med Assoc 288,321-333.
49. Yang Y, Balla A, Danilovich N and Sairam MR (2003) Developmental and molecular aberrations associated with deterioration of oogenesis during complete or partial follicle-stimulating hormone receptor deficiency in mice. Biol Reprod 69,1294-1302.
50. Zheng W, Magid MS, Kramer EE and Chen YT (1996) Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube. Am J Pathol 148,47-53.